Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/103511
Título: | Smouldering multiple sclerosis: the 'real MS' | Autor: | Giovannoni, Gavin Popescu, Veronica Wuerfel, Jens Hellwig, Kerstin Iacobaeus, Ellen Jensen, Michael B García-Domínguez, José Manuel Sousa, Lívia De Rossi, Nicola Hupperts, Raymond Fenu, Giuseppe Bodini, Benedetta Kuusisto, Hanna-Maija Stankoff, Bruno Lycke, Jan Airas, Laura Granziera, Cristina Scalfari, Antonio |
Palavras-chave: | multiple sclerosis; smouldering multiple sclerosis; progression independent of relapse activity; progressive multiple sclerosis | Data: | 2022 | Editora: | SAGE Publications Ltd | Projeto: | Sanofi Genzyme | Título da revista, periódico, livro ou evento: | Therapeutic Advances in Neurological Disorders | Volume: | 15 | Resumo: | Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease of the central nervous system (CNS). We provide a range of evidence to argue that the 'real MS' is in fact driven primarily by a smouldering pathological disease process. In natural history studies and clinical trials, relapses and focal activity revealed by magnetic resonance imaging (MRI) in MS patients on placebo or on disease-modifying therapies (DMTs) were found to be poor predictors of long-term disease evolution and were dissociated from disability outcomes. In addition, the progressive accumulation of disability in MS can occur independently of relapse activity from early in the disease course. This scenario is underpinned by a more diffuse smouldering pathological process that may affect the entire CNS. Many putative pathological drivers of smouldering MS can be potentially modified by specific therapeutic strategies, an approach that may have major implications for the management of MS patients. We hypothesise that therapeutically targeting a state of 'no evident inflammatory disease activity' (NEIDA) cannot sufficiently prevent disability accumulation in MS, meaning that treatment should also focus on other brain and spinal cord pathological processes contributing to the slow loss of neurological function. This should also be complemented with a holistic approach to the management of other systemic disease processes that have been shown to worsen MS outcomes. | URI: | https://hdl.handle.net/10316/103511 | ISSN: | 1756-2856 | DOI: | 10.1177/17562864211066751 | Direitos: | openAccess |
Aparece nas coleções: | FMUC Medicina - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Smouldering-multiple-sclerosis-the-real-MSTherapeutic-Advances-in-Neurological-Disorders.pdf | 938.5 kB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
88
Visto em 15/jul/2024
Citações WEB OF SCIENCETM
71
Visto em 2/jul/2024
Visualizações de página
69
Visto em 16/jul/2024
Downloads
58
Visto em 16/jul/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons